Cited by 622Lipoproteins and Cardiovascular HealthLipid metabolism and disordersCholesterol and Lipid Metabolism

The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.

Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients

Goldberg, Anne C., Hopkins, Paul N., Toth, Peter P., Ballantyne, Christie M., Rader, Daniel J., Robinson, Jennifer G., Daniels, Stephen R., Gidding, Samuel S., de Ferranti, Sarah D., Ito, Matthew K., McGowan, Mary P., Moriarty, Patrick M., Cromwell, William C., Ross, Joyce L., Ziajka, Paul E.·2011·Journal of clinical lipidology

DOI 10.1016/j.jacl.2011.03.001

Open this paper in CoChat — free account

Abstract

The familial hypercholesterolemias (FH) are a group of genetic defects resulting in severe elevations of blood cholesterol levels and increased risk of premature coronary heart disease. FH is among the most commonly occurring congenital metabolic disorders. FH is a treatable disease. Aggressive lipid lowering is necessary to achieve the target LDL cholesterol reduction of at least 50% or more. Even greater target LDL cholesterol reductions may be necessary for FH patients who have other CHD risk factors. Despite the prevalence of this disease and the availability of effective treatment options, FH is both underdiagnosed and undertreated, particularly among children. Deficiencies in the diagnosis and treatment of FH indicate the need for greatly increased awareness and understanding of this disease, both on the part of the public and of healthcare practitioners. This document provides recommendations for the screening, diagnosis and treatment of FH in pediatric and adult patients developed by the National Lipid Association Expert Panel on Familial Hypercholesterolemia. This report goes beyond previously published guidelines by providing specific clinical guidance for the primary care clinician and lipid specialist with the goal of improving care of patients with FH and reducing their elevated risk for CHD.

Integrity signals

Registry

Crossref · 10.1016/j.jacl.2011.03.001

Cites

163 of 163 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
(2005) · The Lancet · doi:10.1016/s0140-6736(05)67394-1 · Cited by 6,848
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
Association between Multiple Cardiovascular Risk Factors and Atherosclerosis in Children and Young Adults
Berenson, G. S., Srinivasan, S. R., Bao, W., Newman, W. P., Tracy, R. E., & Wattigney, W. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806043382302 · Cited by 4,032
The Metabolic Syndrome and Cardiovascular Risk
Mottillo, S., Filion, K. B., Genest, J., Joseph, L., Pilote, L., Poirier, P., Rinfret, S., Schiffrin, E. L., & Eisenberg, M. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.034 · Cited by 3,009
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001282 · Cited by 2,837
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease
Brown, B. G., Zhao, X.-Q., Chait, A., Fisher, L. D., Cheung, M. C., Morse, J. S., Dowdy, A. A., Marino, E. K., Bolson, E. L., Alaupovic, P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011090 · Cited by 1,979
Lipoprotein(a) as a cardiovascular risk factor: current status
Nordestgaard, B. G., Chapman, M. J., Ray, K., Borén, J., Andreotti, F., Watts, G. F., Ginsberg, H., Amarenco, P., Catapano, A., Descamps, O. S., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq386 · Cited by 1,807
Cardiovascular Risk Factors in Childhood and Carotid Artery Intima-Media Thickness in Adulthood: The Cardiovascular Risk in Young Finns Study
Raitakari, O. T., Juonala, M., Kähönen, M., Taittonen, L., Laitinen, T., Mäki-Torkko, N., Järvisalo, M. J., Uhari, M., Jokinen, E., Rönnemaa, T., et al. (2003) · JAMA · doi:10.1001/jama.290.17.2277 · Cited by 1,732
Accumulation of Dietary Cholesterol in Sitosterolemia Caused by Mutations in Adjacent ABC Transporters
Berge, K. E., Tian, H., Graf, G. A., Yu, L., Grishin, N. V., Schultz, J. R., Kwiterovich, P. O., Shan, B., Barnes, R., & Hobbs, H. H. (2000) · Science · doi:10.1126/science.290.5497.1771 · Cited by 1,645
Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis
Rossebø, A. B., Pedersen, T. R., Boman, K., Brudi, P., Chambers, J. B., Egstrup, K., Gerdts, E., Gohlke-Bärwolf, C., Holme, I., Kesäniemi, Y. A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804602 · Cited by 1,644
Executive Summary: Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e3182456d46 · Cited by 1,512
Hyperlipidemia in Coronary Heart Disease II. GENETIC ANALYSIS OF LIPID LEVELS IN 176 FAMILIES AND DELINEATION OF A NEW INHERITED DISORDER, COMBINED HYPERLIPIDEMIA
Goldstein, J. L., Schrott, H. G., Hazzard, W. R., Bierman, E. L., & Motulsky, A. G. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107332 · Cited by 1,444
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR**STELLAR = Statin Therapies for Elevated Lipid Levels compared Across doses to Rosuvastatin. Trial)
Jones, P. H., Davidson, M. H., Stein, E. A., Bays, H. E., McKenney, J. M., Miller, E., Cain, V. A., & Blasetto, J. W. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00530-7 · Cited by 1,392
The Bogalusa Heart Study
Allhoff, P., Laaser, U., & Heinrich, J. (1991) · Springer eBooks · doi:10.1007/978-3-642-95642-3_7 · Cited by 1,331
Lipid screening and cardiovascular health in childhood
Daniels, S. R., Greer, F. R., & and the Committee on Nutrition (2008) · Pediatrics · doi:10.1542/peds.2008-1349 · Cited by 1,178
Self-citation
Relation of Serum Lipoprotein Levels and Systolic Blood Pressure to Early Atherosclerosis
Newman, W. P., Freedman, D. S., Voors, A. W., Gard, P. D., Srinivasan, S. R., Cresanta, J. L., Williamson, G. D., Webber, L. S., & Berenson, G. S. (1986) · New England Journal of Medicine · doi:10.1056/nejm198601163140302 · Cited by 1,063
Lipid Alterations and Decline in the Incidence of Coronary Heart Disease in the Helsinki Heart Study
Manninen, V. (1988) · JAMA · doi:10.1001/jama.1988.03410050061031 · Cited by 954
Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial
Nakamura, H., Arakawa, K., Itakura, H., Kitabatake, A., Goto, Y., Toyota, T., Nakaya, N., Nishimoto, S., Muranaka, M., Yamamoto, A., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69472-5 · Cited by 941
Molecular genetics of the LDL receptor gene in familial hypercholesterolemia
Hobbs, H. H., Brown, M. S., & Goldstein, J. L. (1992) · Human Mutation · doi:10.1002/humu.1380010602 · Cited by 921
Lipid Research Clinics Program
Renfrew, R. A. (1984) · JAMA · doi:10.1001/jama.1984.03350180015009 · Cited by 829
Statin Safety: A Systematic Review
Law, M., & Rudnicka, A. R. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.010 · Cited by 808
Efficacy of statins in familial hypercholesterolaemia: a long term cohort study
Versmissen, J., Oosterveer, D. M., Yazdanpanah, M., Defesche, J. C., Basart, D. C. G., Liem, A. H., Heeringa, J., Witteman, J. C. M., Lansberg, P. J., Kastelein, J. J. P., et al. (2008) · BMJ · doi:10.1136/bmj.a2423 · Cited by 719
National Cholesterol Education Program (NCEP): Highlights of the Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents
Adolescents, N. E. P. O. B. C. L. I. C. A. (1992) · PEDIATRICS · doi:10.1542/peds.89.3.495 · Cited by 688
Genetic Causes of Monogenic Heterozygous Familial Hypercholesterolemia: A HuGE Prevalence Review
Austin, M. A. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh236 · Cited by 657
Efficacy and Safety of Statin Therapy in Children With Familial Hypercholesterolemia
Wiegman, A., Hutten, B. A., de Groot, E., Rodenburg, J., Bakker, H. D., Büller, H. R., Sijbrands, E. J. G., & Kastelein, J. J. P. (2004) · JAMA · doi:10.1001/jama.292.3.331 · Cited by 646
Autosomal Recessive Hypercholesterolemia Caused by Mutations in a Putative LDL Receptor Adaptor Protein
Garcia, C. K., Wilund, K., Arca, M., Zuliani, G., Fellin, R., Maioli, M., Calandra, S., Bertolini, S., Cossu, F., Grishin, N., et al. (2001) · Science · doi:10.1126/science.1060458 · Cited by 624
Molecular biology of PCSK9: its role in LDL metabolism
HORTON, J., COHEN, J., & HOBBS, H. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.12.008 · Cited by 621
Mechanisms of disease: genetic causes of familial hypercholesterolemia
Soutar, A. K., & Naoumova, R. P. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0836 · Cited by 608
Familial lipoprotein disorders in patients with premature coronary artery disease.
Genest, J. J., Martin-Munley, S., McNamara, J. R., Ordovás, J. M., Jenner, J. L., Myers, R. H., Silberman, S. R., Wilson, P. W., Salem, D. N., & Schaefer, E. J. (1992) · Circulation · doi:10.1161/01.cir.85.6.2025 · Cited by 598
A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia
Marks, D., Thorogood, M., Neil, H. A. W., & Humphries, S. E. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00330-1 · Cited by 575
Tracking of Serum Lipids and Lipoproteins from Childhood to Adulthood
Webber, L. S., Srinivasan, S. R., Wattigney, W. A., & Berenson, G. S. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115968 · Cited by 550
Single LDL Apheresis Improves Endothelium-Dependent Vasodilatation in Hypercholesterolemic Humans
Tamai, O., Matsuoka, H., Itabe, H., Wada, Y., Kohno, K., & Imaizumi, T. (1997) · Circulation · doi:10.1161/01.cir.95.1.76 · Cited by 543
Determinants of atherosclerosis in the young
McGill, H. C., & McMahan, C. A. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00720-6 · Cited by 538
Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia
Civeira, F. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.11.010 · Cited by 495
Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis
Briel, M., Ferreira-Gonzalez, I., You, J. J., Karanicolas, P. J., Akl, E. A., Wu, P., Blechacz, B., Bassler, D., Wei, X., Sharman, A., et al. (2009) · BMJ · doi:10.1136/bmj.b92 · Cited by 491
Efficacy and Safety of Ezetimibe Coadministered With Atorvastatin or Simvastatin in Patients With Homozygous Familial Hypercholesterolemia
Gagné, C., Gaudet, D., & Bruckert, É. (2002) · Circulation · doi:10.1161/01.cir.0000018744.58460.62 · Cited by 480
COMMITTEE ON NUTRITION
Lowe, C. U., Coursin, D. B., Heald, F. P., Holliday, M. A., OʼBrien, D., Owen, G. M., Pearson, H. A., Scriver, C. R., Filer, L. J., & Kline, O. L. (1967) · PEDIATRICS · doi:10.1542/peds.40.1.130 · Cited by 478
Hyperlipidemia in Coronary Heart Disease
Goldstein, J. L., HAzzmm, W. R., ScinoTT, H. G., Bierman, E. L., Levinski, M. J., & Campbell, E. D. (1973) · Cited by 471
Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force
McKenney, J. M., Davidson, M. H., Jacobson, T. A., & Guyton, J. R. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.02.030 · Cited by 431
Associations of Coronary Heart Disease Risk Factors With the Intermediate Lesion of Atherosclerosis in Youth
McGill, H. C., McMahan, C. A., Zieske, A. W., Sloop, G. D., Walcott, J. V., Troxclair, D. A., Malcom, G. T., Tracy, R. E., Oalmann, M. C., & Strong, J. P. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.8.1998 · Cited by 421
Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents: A Scientific Statement From the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, With the Council on Cardiovascular Nursing
McCrindle, B. W., Urbina, E. M., Dennison, B. A., Jacobson, M. S., Steinberger, J., Rocchini, A. P., Hayman, L. L., & Daniels, S. R. (2007) · Circulation · doi:10.1161/circulationaha.107.181946 · Cited by 418
Self-citation
Pleiotropic Effects of Statins: Benefit Beyond Cholesterol Reduction?
Robinson, J. G., Smith, B., Maheshwari, N., & Schrott, H. G. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.085 · Cited by 409
Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management
(1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00200-7 · Cited by 396
Distributions and Trends of Serum Lipid Levels among United States Children and Adolescents Ages 4–19 Years: Data from the Third National Health and Nutrition Examination Survey
Hickman, T. B., BRIEFEL, R. R., Carroll, M. D., Rifkind, B. M., Cleeman, J. I., Maurer, K. R., & Johnson, C. L. (1998) · Preventive Medicine · doi:10.1006/pmed.1998.0376 · Cited by 374
Early statin therapy restores endothelial function in children with familial hypercholesterolemia
de Jongh, S., Liliën, M. R., Roodt, J. O. ’., Stroes, E. S. G., Bakker, H. D., & Kastelein, J. J. P. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02593-7 · Cited by 366
Familial Hypercholesterolemia and Coronary Heart Disease: A HuGE Association Review
Austin, M. A. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh237 · Cited by 361
Familial Hypercholesterolemias: Prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
Hopkins, P. N., Toth, P. P., Ballantyne, C. M., & Rader, D. J. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.03.452 · Cited by 357
Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia.
Innerarity, T., Mahley, R., Weisgraber, K., Bersot, T., Krauss, R., Vega, G., Grundy, S., Friedl, W., Davignon, J., & McCarthy, B. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42605-7 · Cited by 352
Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
SHARP Collaborative Group (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.08.012 · Cited by 319
Efficacy and Safety of Statin Therapy in Children With Familial Hypercholesterolemia
de Jongh, S., Ose, L., Szamosi, T., Gagné, C., Lambert, M. A., Scott, R. S., Perron, P., Dobbelaere, D., Saborio, M., Tuohy, M. B., et al. (2002) · Circulation · doi:10.1161/01.cir.0000035247.42888.82 · Cited by 308
The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients
Jansen, A. C. M., van Aalst-Cohen, E. S., Tanck, M. W. T., Trip, M. D., Lansberg, P. J., Liem, A. H., van Lennep, H. W. O. R., Sijbrands, E. J. G., & Kastelein, J. J. P. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01405.x · Cited by 302
Deletion in the Gene for the Low-Density-Lipoprotein Receptor in a Majority of French Canadians with Familial Hypercholesterolemia
Hobbs, H. H., Brown, M. S., Russell, D. W., Davignon, J., & Goldstein, J. L. (1987) · New England Journal of Medicine · doi:10.1056/nejm198709173171204 · Cited by 301
Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia
Mabuchi, H., Koizumi, J., Shimizu, M., Kajinami, K., Miyamoto, S., Ueda, K., & Takegoshi, T. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00692-4 · Cited by 293
Statin Treatment in Children With Familial Hypercholesterolemia
Rodenburg, J., Vissers, M. N., Wiegman, A., van Trotsenburg, A. S. P., van der Graaf, A., de Groot, E., Wijburg, F. A., Kastelein, J. J. P., & Hutten, B. A. (2007) · Circulation · doi:10.1161/circulationaha.106.671016 · Cited by 287
LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis.
Kroon, A. A., Aengevaeren, W. R. M., van der Werf, T., Uijen, G. J. H., Reiber, J. H. C., Bruschke, A. V. G., & Stalenhoef, A. F. H. (1996) · PubMed · doi:10.1161/01.cir.93.10.1826 · Cited by 275
Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis
Bruckert, E., Labreuche, J., & Amarenco, P. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.12.023 · Cited by 273
Recommendations for the use of LDL apheresis
Thompson, G. R. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.02.009 · Cited by 270
An Assessment of Statin Safety by Hepatologists
Cohen, D. E., Anania, F. A., & Chalasani, N. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.014 · Cited by 269
Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk
Humphries, S. E., Whittall, R. A., Hubbart, C. S., Maplebeck, S., Cooper, J. A., Soutar, A. K., Naoumova, R., Thompson, G. R., Seed, M., Durrington, P. N., et al. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.038356 · Cited by 267
Statins for children with familial hypercholesterolemia
Vuorio, A. F., Kuoppala, J., Kovanen, P. T., Humphries, S. E., Tonstad, S., Wiegman, A., Drogari, E., & Ramaswami, U. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006401.pub4 · Cited by 264
An Assessment of Statin Safety by Muscle Experts
Thompson, P. D., Clarkson, P. M., & Rosenson, R. S. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.013 · Cited by 263
Effects of smoking and smoking cessation on lipids and lipoproteins: Outcomes from a randomized clinical trial
Gepner, A. D., Piper, M. E., Johnson, H. M., Fiore, M. C., Baker, T. B., & Stein, J. H. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.09.023 · Cited by 249
Lipid disorders and mutations in the APOB gene
Whitfield, A. J., Barrett, P. H. R., van Bockxmeer, F. M., & Burnett, J. R. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.038026 · Cited by 243
Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in The Netherlands
Pijlman, A. H., Huijgen, R., Verhagen, S. N., Imholz, B. P. M., Liem, A. H., Kastelein, J. J. P., Abbink, E. J., Stalenhoef, A. F. H., & Visseren, F. L. J. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.09.014 · Cited by 238
Familial hypercholesterolaemia: summary of NICE guidance
Wierzbicki, A. S., Humphries, S. E., Minhas, R., & on behalf of the Guideline Development Group (2008) · BMJ · doi:10.1136/bmj.a1095 · Cited by 237
THE LDL RECEPTOR LOCUS AND THE GENETICS OF FAMILIAL HYPERCHOLESTEROLEMIA
Goldstein, J. L., & Brown, M. S. (1979) · Annual Review of Genetics · doi:10.1146/annurev.ge.13.120179.001355 · Cited by 233
ARH Is a Modular Adaptor Protein That Interacts with the LDL Receptor, Clathrin, and AP-2
He, G., Gupta, S., Yi, M., Michaely, P., Hobbs, H. H., & Cohen, J. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208539200 · Cited by 232
Analyses of Cancer Data from Three Ezetimibe Trials
Peto, R., Emberson, J., Landray, M., Baigent, C., Collins, R., Clare, R. M., & Califf, R. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa0806603 · Cited by 230
Nutraceuticals and Atherosclerosis: Human Trials
Badimón, L., Vilahur, G., & Padró, T. (2010) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00189.x · Cited by 227
Does Carotid Intima-Media Thickness Regression Predict Reduction of Cardiovascular Events?
Costanzo, P., Filardi, P. P., Vassallo, E., Paolillo, S., Cesarano, P., Brevetti, G., & Chiariello, M. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.059 · Cited by 225
Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia
Marks, D., Wonderling, D. E., Thorogood, M., Lambert, H., Humphries, S. E., & Neil, H. A. W. (2002) · BMJ · doi:10.1136/bmj.324.7349.1303 · Cited by 221
Risk Scores Predict Atherosclerotic Lesions in Young People
McMahan, C. A. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.8.883 · Cited by 219
The molecular basis of familial hypercholesterolemia in The Netherlands
Fouchier, S. W., Defesche, J. C., Umans-Eckenhausen, M. A. W., & Kastelein, J. J. P. (2001) · Human Genetics · doi:10.1007/s00439-001-0628-8 · Cited by 203
Recognition and Management of Dyslipidemia in Children and Adolescents
Kwiterovich, P. O. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1270 · Cited by 203
Screening and Treatment for Lipid Disorders in Children and Adolescents: Systematic Evidence Review for the US Preventive Services Task Force
Haney, E. M., Huffman, L. H., Bougatsos, C., Freeman, M., Steiner, R. D., & Nelson, H. D. (2007) · PEDIATRICS · doi:10.1542/peds.2006-1801 · Cited by 202
Genetic heterogeneity of autosomal dominant hypercholesterolemia
Varret, M., Abifadel, M., Rabès, J., & Boileau, C. (2007) · Clinical Genetics · doi:10.1111/j.1399-0004.2007.00915.x · Cited by 202
Psychological impact of genetic testing for familial hypercholesterolemia within a previously aware population: A randomized controlled trial
Marteau, T. M., Senior, V., Humphries, S. E., Bobrow, M., Cranston, T., Crook, M. A., Day, L., Fernandez, M. C., Horne, R., Iversen, A., et al. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30102 · Cited by 194
Experiences with the Homozygous Cases of Familial Hypercholesterolemia
Khachadurian, A. K., & Uthman, S. M. (1973) · Annals of Nutrition and Metabolism · doi:10.1159/000175431 · Cited by 185
Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis
Wald, D. S., Bestwick, J. P., & Wald, N. (2007) · BMJ · doi:10.1136/bmj.39300.616076.55 · Cited by 184
Controlled Trial of Soya-Bean Oil in Myocardial Infarction
Allhoff, P., Laaser, U., & Heinrich, J. (1991) · Springer eBooks · doi:10.1007/978-3-642-95642-3_15 · Cited by 179
Current Status of Cardiovascular Gene Therapy
Rissanen, T. T., & Ylä‐Herttuala, S. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300175 · Cited by 177
Pediatric aspects of Familial Hypercholesterolemias: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
Daniels, S. R., Gidding, S. S., & de Ferranti, S. D. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.03.453 · Cited by 173
Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia.
Hill, J. S., Hayden, M. R., Frohlich, J., & Pritchard, P. H. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.2.290 · Cited by 172
Safety of Aggressive Lipid Management
Davidson, M. H., & Robinson, J. G. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.067 · Cited by 166
Population genetic screening programmes: principles, techniques, practices, and policies
Godard, B., ten Kate, L. P., Evers‐Kiebooms, G., & Aymé, S. (2003) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201113 · Cited by 152
The Molecular Mechanism for the Genetic Disorder Familial Defective Apolipoprotein B100
Borén, J., Ekström, U., Agren, B., Nilsson‐Ehle, P., & Innerarity, T. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008890200 · Cited by 147
Assessing pain and analgesia with a lidocaine-prilocaine emulsion in infants and toddlers during venipuncture
Robieux, I., Kumar, R., Radhakrishnan, S., & Koren, G. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)82220-6 · Cited by 141
Management of Familial Hypercholesterolemias in adult patients: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
Ito, M. K., McGowan, M. P., & Moriarty, P. M. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.04.001 · Cited by 139
Distribution and Correlates of Non-High-Density Lipoprotein Cholesterol in Children: The Bogalusa Heart Study
Srinivasan, S. R., Myers, L., & Berenson, G. S. (2002) · PEDIATRICS · doi:10.1542/peds.110.3.e29 · Cited by 138
Efficacy and safety of coadministration of ezetimibe and simvastatin in adolescents with heterozygous familial hypercholesterolemia.
van der Graaf, A., Cuffie-Jackson, C., Vissers, M., Trip, M., Gagné, C., Shi, G., Veltri, E., Avis, H., & Kastelein, J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.09.002 · Cited by 134
Cost-Effectiveness Analysis of the Genetic Screening Program for Familial Hypercholesterolemia in the Netherlands
Wonderling, D. E., Umans-Eckenhausen, M. A. W., Marks, D., Defesche, J. C., Kastelein, J. J. P., & Thorogood, M. (2004) · Seminars in Vascular Medicine · doi:10.1055/s-2004-822992 · Cited by 134
The HELP‐LDL‐apheresis multicentre study, an angiographically assessed trial on the role of LDL‐apheresis in the secondary prevention of coronary heart disease
Seidel, D., Armstrong, V. W., & Schuff‐Werner, P. (1991) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1991.tb01384.x · Cited by 127
Efficacy and Safety of Lovastatin Therapy in Adolescent Girls With Heterozygous Familial Hypercholesterolemia
Clauss, S. B., Holmes, K. W., Hopkins, P. N., Stein, E. A., Cho, M., Tate, A. C., Johnson‐Levonas, A. O., & Kwiterovich, P. O. (2005) · PEDIATRICS · doi:10.1542/peds.2004-2090 · Cited by 124
Differences in characteristics and risk of cardiovascular disease in familial hypercholesterolemia patients with and without tendon xanthomas: A systematic review and meta-analysis
Oosterveer, D. M., Versmissen, J., Yazdanpanah, M., Hamza, T. H., & Sijbrands, E. J. G. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.04.009 · Cited by 124
Treatment of adults with Familial Hypercholesterolemia and evidence for treatment: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
Robinson, J. G., & Goldberg, A. C. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.03.451 · Cited by 120
Lipid and lipoprotein distributions in white children ages 6–19 yr. The lipid research clinics program prevalence study
Tamir, I., HEISS, G. M., Glueck, C. J., CHRISTENSEN, B. L., Kwiterovich, P. O., & Rifkind, B. M. (1981) · Journal of Chronic Diseases · doi:10.1016/0021-9681(81)90079-5 · Cited by 116
Systematic Examination of the Updated Framingham Heart Study General Cardiovascular Risk Profile
Perak, A. M., & Lloyd‐Jones, D. M. (2009) · Circulation · doi:10.1161/circulationaha.108.835470 · Cited by 113
Outcome of case finding among relatives of patients with known heterozygous familial
Bhatnagar, D. (2000) · BMJ · doi:10.1136/bmj.321.7275.1497 · Cited by 113
Lipoprotein(a) and ischemic heart disease—A causal association? A review
Kamstrup, P. R. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.12.036 · Cited by 112
Long-Term Effects of Low-Density Lipoprotein Apheresis Using an Automated Dextran Sulfate Cellulose Adsorption System fn1fn1This study was supported by a grant from the Kaneka America Corporation, New York, New York.
Gordon, B. R., Kelsey, S. F., Dau, P. C., Gotto, A. M., Graham, K. J., Illingworth, D. R., Isaacsohn, J. L., Jones, P. H., Leitman, S. F., Saal, S. D., et al. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00947-8 · Cited by 110
Executive Summary: Heart Disease and Stroke Statistics—2011 Update
Roger, V. L., Go, A. S., Lloyd‐Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., Carnethon, M. R., Dai, S., SIMONE, G. D., Ford, E. S., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31820c7a50 · Cited by 107
Niacin Treatment of Hypercholesterolemia in Children
Colletti, R. B., Roff, N. K., Neufeld, E. J., Baker, A., Newburger, J. W., & McAuliffe, T. L. (1993) · PEDIATRICS · doi:10.1542/peds.92.1.78 · Cited by 106
Low‐dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low‐density lipoprotein cholesterol in patients with primary hypercholesterolemia
Davidson, M. H., Toth, P. D., Weiss, S. R., McKenney, J. M., Hunninghake, D., Isaacsohn, J. L., Donovan, J. M., & Burke, S. K. (2001) · Clinical Cardiology · doi:10.1002/clc.4960240610 · Cited by 103
Family history as an independent risk factor for incident coronary artery disease in a high-risk cohort in Utah
Hopkins, P. N., Williams, R. R., Kuida, H., Stults, B. M., Hunt, S. C., Barlow, G. K., & Ash, K. O. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)91206-4 · Cited by 102
Treatment of hyperlipidemia with combined niacin–statin regimens
Guyton, J. R., & Capuzzi, D. M. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00955-2 · Cited by 98
Clinical trial experience with extended-release niacin (niaspan): dose-escalation study
Goldberg, A. C. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00952-7 · Cited by 95
Effect of Plant Stanol Tablets on Low-Density Lipoprotein Cholesterol Lowering in Patients on Statin Drugs
Goldberg, A. C., Ostlund, R. E., Bateman, J., Schimmoeller, L., McPherson, T. B., & Spilburg, C. A. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.08.056 · Cited by 94
Genetic screening protocol for familial hypercholesterolemia which includes splicing defects gives an improved mutation detection rate
Graham, C. A., McIlhatton, B. P., Kirk, C. W., Beattie, E. D., Lyttle, K., Hart, P., Neely, R. D. G., Young, I. S., & Nicholls, D. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.02.016 · Cited by 94
Sensitivity and Specificity of Pediatric Lipid Determinations for Adult Lipid Status: Findings From the Princeton Lipid Research Clinics Prevalence Program Follow-up Study
Friedman, L. A., Morrison, J. A., Daniels, S. R., McCarthy, W. F., & Sprecher, D. L. (2006) · PEDIATRICS · doi:10.1542/peds.2005-2968 · Cited by 93
Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia
Real, J. T. (2001) · European Heart Journal · doi:10.1053/euhj.2000.2408 · Cited by 93
Population-Based Frequency of Dyslipidemia Syndromes in Coronary-Prone Families in Utah
Williams, R. R. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390150076015 · Cited by 90
Family history evaluation as a predictive screen for childhood hypercholesterolemia. Pediatric Practice Research Group.
Griffin, T. C., Christoffel, K. K., Binns, H. J., & McGuire, P. A. (1989) · PubMed · Cited by 89
Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: A randomized, crossover trial
McCrindle, B. W., O'Neill, M. B., Cullen-Dean, G., & Helden, E. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70353-6 · Cited by 89
Evaluation of subclinical atherosclerosis by computed tomography coronary angiography and its association with risk factors in familial hypercholesterolemia
Miname, M. H., Ribeiro, M. S., Filho, J. P., Ávila, L. F., Bortolotto, L. A., Martinez, L. R. C., Rochitte, C. E., & Santos, R. D. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.10.001 · Cited by 85
United states cholesterol guidelines 2001: expanded scope of intensive low-density lipoprotein–lowering therapy
Grundy, S. M. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01931-2 · Cited by 80
A Randomized Crossover Trial of Combination Pharmacologic Therapy in Children with Familial Hyperlipidemia
McCrindle, B. W., Helden, E., Cullen-Dean, G., & Conner, W. T. (2002) · Pediatric Research · doi:10.1203/00006450-200206000-00009 · Cited by 78
Identification of deletions in the human low density lipoprotein receptor gene.
Horsthemke, B., Dunning, A., & Humphries, S. E. (1987) · Journal of Medical Genetics · doi:10.1136/jmg.24.3.144 · Cited by 76
Identifying patients with familial hypercholesterolaemia in primary care: an informatics-based approach in one primary care centre
Gray, J., Jaiyeola, A. J., Whiting, M., Modell, M., & Wierzbicki, A. S. (2007) · Heart · doi:10.1136/hrt.2006.107391 · Cited by 76
MANAGEMENT OF HYPERCHOLESTEROLEMIA
Illingworth, D. R. (2000) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70205-4 · Cited by 75
Lowering LDL-cholesterol through diet: potential role in the statin era
Bruckert, É., & Rosenbaum, D. H. (2011) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328340b8e7 · Cited by 70
Impact of Statin Treatment on the Clinical Fate of Heterozygous Familial Hypercholesterolemia
Harada-Shiba, M., Sugisawa, T., Makino, H., Abe, M., Tsushima, M., Yoshimasa, Y., Yamashita, T., Miyamoto, Y., Yamamoto, A., Tomoike, H., et al. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.4143 · Cited by 70
Neonatal Diagnosis of Familial Type II Hyperlipoproteinemia
ANDERSEN, G. E., & Friis-Hansen, B. (1976) · PEDIATRICS · doi:10.1542/peds.57.2.214 · Cited by 68
Long-term safety and efficacy of high-dose atorvastatin treatment in patients with familial hypercholesterolemia
van Wissen, S., Smilde, T. J., Trip, M. D., Stalenhoef, A. F. H., & Kastelein, J. J. P. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.09.015 · Cited by 64
Observed and Predicted Reduction of Ischemic Cardiovascular Events in the Simvastatin and Ezetimibe in Aortic Stenosis Trial
Holme, I., Boman, K., Brudi, P., Egstrup, K., Gohlke-Baerwolf, C., Kesäniemi, Y. A., Malbecq, W., Rossebø, A. B., Wachtell, K., Willenheimer, R. B., et al. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.01.363 · Cited by 62
Differential Indication of Lipoprotein Apheresis During Pregnancy
Klingel, R., Göhlen, B., Schwarting, A., Himmelsbach, F., & Straube, R. (2003) · Therapeutic Apheresis and Dialysis · doi:10.1046/j.1526-0968.2003.00066.x · Cited by 60
Implementation of cascade testing for the detection of familial hypercholesterolaemia
Hadfield, S. G., & Humphries, S. E. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000174152.76554.d6 · Cited by 60
Cholesterol screening in childhood: Sixteen-year Beaver Coynty Lipid Study experience
Stuhldreher, W. L., Orchard, T. J., Donahue, R. P., Kuller, L. H., Gloninger, M. F., & DRASH, A. L. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)82403-5 · Cited by 55
Long-term prognostic factors of young patients (≤ 35 years) having acute myocardial infarction: the detrimental role of continuation of smoking
Rallidis, L. S., Lekakis, J. P., Panagiotakos, D. B., Fountoulaki, K., Komporozos, C., Apostolou, T. S., Rizos, L., & Kremastinos, D. T. (2008) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e32830774db · Cited by 55
Failure of Current Guidelines for Cholesterol Screening in Urban African-American Adolescents
Rifai, N., Neufeld, E. J., Ahlstrom, P., Rimm, E. B., D’Angelo, L. J., & Hicks, J. M. (1996) · PEDIATRICS · doi:10.1542/peds.98.3.383 · Cited by 54
Familial hypercholesterolemia: a missed opportunity in preventive medicine
Watts, G. F., Lewis, B., & SULLIVAN, D. R. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0941 · Cited by 53
Evaluation of the Antihyperlipidemic Properties of Dietary Supplements
Caron, M. F., & White, C. M. (2001) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.5.481.34499 · Cited by 49
Documented need for more effective diagnosis and treatment of familial hypercholesterolemia according to data from 502 heterozygotes in Utah
Williams, R. R., Schumacher, M. C., Barlow, G. K., Hunt, S. C., Ware, J. L., Pratt, M., & Latham, B. D. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90006-x · Cited by 47
Effects of a Stanol-Enriched Diet on Plasma Cholesterol and Triglycerides in Patients Treated with Statins
Cabezas, M. C., de Vries, J. H. M., van Oostrom, A. J. H. H. M., Iestra, J. A., & van Staveren, W. A. (2006) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2006.07.009 · Cited by 47
Cost-effectiveness of a family and DNA based screening programme on familial hypercholesterolaemia in The Netherlands
de Mheen, P. J. M. (2002) · European Heart Journal · doi:10.1053/euhj.2002.3281 · Cited by 46
Challenges to Implementing the Current Pediatric Cholesterol Screening Guidelines Into Practice
Dennison, B. A., Jenkins, P., & Pearson, T. A. (1994) · PEDIATRICS · doi:10.1542/peds.94.3.296 · Cited by 44
Identifying Patients for Aggressive Cholesterol Lowering: The Risk Curve Concept
Robinson, J. G., & Stone, N. J. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.06.039 · Cited by 44
Molecular screening for familial hypercholesterolaemia: consequences for life and disability insurance
Homsma, S. J. M., Huijgen, R., Middeldorp, S., Sijbrands, E. J. G., & Kastelein, J. J. P. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201940 · Cited by 43
Plasma lipoprotein distribution of apolipoprotein E in familial hypercholesterolemia.
Gibson, J. C., Goldberg, R. B., Rubinstein, A., Ginsberg, H. N., Brown, W. V., Baker, S. G., Joffe, B. I., & Seftel, H. C. (1987) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.7.4.401 · Cited by 40
Relative contribution of low-density lipoprotein receptor and lipoprotein lipase gene mutations to angiographically assessed coronary artery disease among French Canadians
Gaudet, D., Vohl, M., Julien, P., Tremblay, G., Perron, P., Gagné, C., Bergeron, J., Moorjani, S., & Després, J. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00328-2 · Cited by 40
Apheresis in Coronary Heart Disease With Elevated Lp (a): A Review of Lp (a) As a Risk Factor and Its Management
Keller, C. (2007) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2007.00449.x · Cited by 37
Cholesterol-lowering drug therapy in a patient with receptor-negative homozygous familial hypercholesterolaemia
Feher, M. D., Webb, J. C., Patel, D. D., Lant, A. F., Mayne, P., Knight, B. L., & Soutar, A. K. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90260-2 · Cited by 37
Familial defective apolipoprotein B-100: mild hypercholesterolaemia without atherosclerosis in a homozygous patient
März, W., Ruzicka, C., Pohl, T., Usadel, K. H., & Gross, W. (1992) · The Lancet · doi:10.1016/0140-6736(92)92554-s · Cited by 35
Getting insurance after genetic screening on familial hypercholesterolaemia; the need to educate both insurers and the public to increase adherence to national guidelines in the Netherlands: Table 1
de Mheen, P. J. M., van Maarle, M. C., & Stouthard, M. E. A. (2002) · Journal of Epidemiology & Community Health · doi:10.1136/jech.56.2.145 · Cited by 33
The relation of apolipoprotein E polymorphism to multiple cardiovascular risk in children: the Bogalusa heart study
Srinivasan, S. R., Ehnholm, C., Wattigney, W. A., Bao, W., & Berenson, G. S. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05762-5 · Cited by 33
Coexisting dysbetalipoproteinemia and familial hypercholesterolemia
Carmena, R., Roy, M., Roederer, G. O., Minnich, A., & Davignon, J. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00212-9 · Cited by 32
Future issues, public policy, and public awareness of Familial Hypercholesterolemias: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
Goldberg, A. C., Robinson, J. G., Cromwell, W. C., Ross, J. L., & Ziajka, P. E. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.04.002 · Cited by 31
Disease Knowledge and Adherence to Treatment in Patients With Familial Hypercholesterolemia
Hollman, G., OLSSON, A. G., & Ek, A. (2006) · The Journal of Cardiovascular Nursing · doi:10.1097/00005082-200603000-00005 · Cited by 30
Effect of statin treatment for familial hypercholesterolaemia on life assurance: results of consecutive surveys in 1990 and 2002
Neil, H. A. W., Hammond, T., Mant, D., & Humphries, S. E. (2004) · BMJ · doi:10.1136/bmj.328.7438.500 · Cited by 30
Coronary Drug Project
Cáceres, C. A. (1978) · JAMA · doi:10.1001/jama.1978.03280520027005 · Cited by 28
LDL-apheresis therapy
Moriarty, P. M. (2006) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-006-0049-z · Cited by 26
Parental attitude towards genetic testing for familial hypercholesterolaemia in children
Umans-Eckenhausen, M. A. W., Oort, F. J., Ferenschild, K. C. M. P., Defesche, J. C., Kastelein, J. J. P., & de Haes, J. C. J. M. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.9.e49 · Cited by 26
A New Model of Care for Familial Hypercholesterolaemia from Western Australia: Closing a Major Gap in Preventive Cardiology
Watts, G. F., BOCKXMEER, F. M. V., Bates, T. R., Burnett, J. R., Juniper, A., & O'Leary, P. C. (2010) · Heart Lung and Circulation · doi:10.1016/j.hlc.2010.02.002 · Cited by 23
The effect of LDL apheresis on progression of coronary artery disease in patients with familial hypercholesterolemia
Waidner, T., Franzen, D., Voelker, W., Ritter, M., Borberg, H., Hombach, V., & Höpp, H. (1994) · Clinical Investigation · doi:10.1007/bf00190741 · Cited by 23
Statins and Children
Stein, E. A. (2007) · Circulation · doi:10.1161/circulationaha.107.717777 · Cited by 22
Changes in Oxidative Stress and Microcirculation by Low‐density Lipoprotein Apheresis
Sato, M., & Amano, I. (2003) · Therapeutic Apheresis and Dialysis · doi:10.1046/j.1526-0968.2003.00078.x · Cited by 19
Ethical Issues in Molecular Screening for Heterozygous Familial Hypercholesterolemia: The Complexity of Dealing with Genetic Susceptibility to Coronary Artery Disease
Gaudet, D., Gagné, C., Perron, P., Couture, P., & Tonstad, S. (1999) · Public Health Genomics · doi:10.1159/000016176 · Cited by 12
Childhood Cardiovascular Risk Factors and Carotid Vascular Changes in Adulthood: The Bogalusa Heart Study
Li, S., Chen, W., Srinivasan, S. R., Bond, M. G., Tang, R., Urbina, E. M., & Berenson, G. S. (2003) · JAMA · doi:10.1001/jama.290.17.2271 · Cited by 8
Commentary: What's so special about familial hypercholesterolaemia?
Mant, D. (2009) · British Journal of General Practice · doi:10.3399/bjgp09x472683 · Cited by 6

Flagged first, then by citations

Sorted by citations

Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Heart disease and stroke statistics-2018 update: a report from the american heart association
Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
Nordestgaard, B. G., Chapman, M. J., Humphries, S. E., Ginsberg, H. N., Masana, L., Descamps, O. S., Wiklund, O., Hegele, R. A., Raal, F. J., Defesche, J. C., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht273 · Cited by 2,761
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
Cuchel, M., Bruckert, E., Ginsberg, H. N., Raal, F. J., Santos, R. D., Hegele, R. A., Kuivenhoven, J. A., Nordestgaard, B. G., Descamps, O. S., Steinhagen-Thiessen, E., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu274 · Cited by 1,057
Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia
Khera, A. V., Won, H.-H., Peloso, G. M., Lawson, K. S., Bartz, T. M., Deng, X., van Leeuwen, E. M., Natarajan, P., Emdin, C. A., Bick, A. G., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.520 · Cited by 942

See all 622

Authors: Goldberg, A. C., Hopkins, P. N., Toth, P. P., Ballantyne, C. M., Rader, D. J., Robinson, J. G., Daniels, S. R., Gidding, S. S., de Ferranti, S. D., Ito, M. K., McGowan, M. P., Moriarty, P. M., Cromwell, W. C., Ross, J. L., & Ziajka, P. E.
Affiliations: Washington University in St. Louis (US)
University of Utah (US)
CGH Medical Center (US)
Baylor College of Medicine (US)
University of Pennsylvania (US)
University of Iowa (US)
Children's Hospital Colorado (US)
Alfred I. duPont Hospital for Children (US)
Oregon State University (US)
Concord Hospital (US)
University of Kansas Medical Center (US)
Wake Forest University (US)
University of Pennsylvania Health System (US)
Corresponding author: Goldberg, Anne C.
ORCID: Goldberg, Anne C.
Hopkins, Paul N.
Toth, Peter P.
Ballantyne, Christie M.
Rader, Daniel J.
Robinson, Jennifer G.
Daniels, Stephen R.
Gidding, Samuel S.
McGowan, Mary P.
Moriarty, Patrick M.
Cromwell, William C.
Venue: Journal of clinical lipidology
Publisher: Elsevier BV
Published: 2011-05
Volume: 5
Issue: 3
Pages: 133-140
ISSN: 1876-4789 (ISSN-L)
1933-2874
DOI: 10.1016/j.jacl.2011.03.001
OpenAlex: W2943032204
Cited by: 622
References: 163
Citations by year: 2026: 13 · 2025: 16 · 2024: 15 · 2023: 22 · 2022: 23 · 2021: 55 · 2020: 53 · 2019: 39 · 2018: 63 · 2017: 47 · 2016: 76 · 2015: 58 · 2014: 56 · 2013: 47 · 2012: 28
FWCI: 45.77
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Journal of clinical lipidology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Keywords: familial hypercholesterolemia, screening, diagnosis, lipid-lowering therapy, LDL cholesterol lowering, coronary heart disease risk, pediatric patients, underdiagnosis, primary care, genetic lipid disorders
MeSH terms: Proprotein Convertase 9, Adult, Anticholesteremic Agents, Apolipoproteins B, Child, Coronary Disease, Genetic Testing, Homozygote, Humans, Hyperlipoproteinemia Type II, Mutation, Serine Endopeptidases, Practice Guidelines as Topic, LDL-Receptor Related Proteins, Proprotein Convertases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks